Cargando…
Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study
BACKGROUND: Even in absence of obstructive coronary artery disease women with angina pectoris have a poor prognosis possibly due to coronary microvascular disease. Coronary microvascular disease can be assessed by transthoracic Doppler echocardiography measuring coronary flow velocity reserve (CFVR)...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096323/ https://www.ncbi.nlm.nih.gov/pubmed/27809867 http://dx.doi.org/10.1186/s12968-016-0295-5 |
_version_ | 1782465450475520000 |
---|---|
author | Mygind, Naja Dam Michelsen, Marie Mide Pena, Adam Qayyum, Abbas Ali Frestad, Daria Christensen, Thomas Emil Ghotbi, Adam Ali Dose, Nynne Faber, Rebekka Vejlstrup, Niels Hasbak, Philip Kjaer, Andreas Prescott, Eva Kastrup, Jens |
author_facet | Mygind, Naja Dam Michelsen, Marie Mide Pena, Adam Qayyum, Abbas Ali Frestad, Daria Christensen, Thomas Emil Ghotbi, Adam Ali Dose, Nynne Faber, Rebekka Vejlstrup, Niels Hasbak, Philip Kjaer, Andreas Prescott, Eva Kastrup, Jens |
author_sort | Mygind, Naja Dam |
collection | PubMed |
description | BACKGROUND: Even in absence of obstructive coronary artery disease women with angina pectoris have a poor prognosis possibly due to coronary microvascular disease. Coronary microvascular disease can be assessed by transthoracic Doppler echocardiography measuring coronary flow velocity reserve (CFVR) and by positron emission tomography measuring myocardial blood flow reserve (MBFR). Diffuse myocardial fibrosis can be assessed by cardiovascular magnetic resonance (CMR) T1 mapping. We hypothesized that coronary microvascular disease is associated with diffuse myocardial fibrosis. METHODS: Women with angina, a clinically indicated coronary angiogram with <50 % stenosis and no diabetes were included. CFVR was measured using dipyridamole (0.84 mg/kg) and MBFR using adenosine (0.84 mg/kg). Focal fibrosis was assessed by 1.5 T CMR late gadolinium enhancement (0.1 mmol/kg) and diffuse myocardial fibrosis by T1 mapping using a modified Look-Locker pulse sequence measuring T1 and extracellular volume fraction (ECV). RESULTS: CFVR and CMR were performed in 64 women, mean (SD) age 62.5 (8.3) years. MBFR was performed in a subgroup of 54 (84 %) of these women. Mean native T1 was 1023 (86) and ECV (%) was 33.7 (3.5); none had focal fibrosis. Median (IQR) CFVR was 2.3 (1.9; 2.7), 23 (36 %) had CFVR < 2 indicating coronary microvascular disease, and median MBFR was 2.7 (2.2; 3.0) and 19 (35 %) had a MBFR value below 2.5. No significant correlations were found between CFVR and ECV or native T1 (R (2) = 0.02; p = 0.27 and R (2) = 0.004; p = 0.61, respectively). There were also no correlations between MBFR and ECV or native T1 (R (2) = 0.1; p = 0.13 and R (2) = 0.004, p = 0.64, respectively). CFVR and MBFR were correlated to hypertension and heart rate. CONCLUSION: In women with angina and no obstructive coronary artery disease we found no association between measures of coronary microvascular disease and myocardial fibrosis, suggesting that myocardial ischemia induced by coronary microvascular disease does not elicit myocardial fibrosis in this population. The examined parameters seem to provide independent information about myocardial and coronary disease. |
format | Online Article Text |
id | pubmed-5096323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50963232016-11-07 Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study Mygind, Naja Dam Michelsen, Marie Mide Pena, Adam Qayyum, Abbas Ali Frestad, Daria Christensen, Thomas Emil Ghotbi, Adam Ali Dose, Nynne Faber, Rebekka Vejlstrup, Niels Hasbak, Philip Kjaer, Andreas Prescott, Eva Kastrup, Jens J Cardiovasc Magn Reson Research BACKGROUND: Even in absence of obstructive coronary artery disease women with angina pectoris have a poor prognosis possibly due to coronary microvascular disease. Coronary microvascular disease can be assessed by transthoracic Doppler echocardiography measuring coronary flow velocity reserve (CFVR) and by positron emission tomography measuring myocardial blood flow reserve (MBFR). Diffuse myocardial fibrosis can be assessed by cardiovascular magnetic resonance (CMR) T1 mapping. We hypothesized that coronary microvascular disease is associated with diffuse myocardial fibrosis. METHODS: Women with angina, a clinically indicated coronary angiogram with <50 % stenosis and no diabetes were included. CFVR was measured using dipyridamole (0.84 mg/kg) and MBFR using adenosine (0.84 mg/kg). Focal fibrosis was assessed by 1.5 T CMR late gadolinium enhancement (0.1 mmol/kg) and diffuse myocardial fibrosis by T1 mapping using a modified Look-Locker pulse sequence measuring T1 and extracellular volume fraction (ECV). RESULTS: CFVR and CMR were performed in 64 women, mean (SD) age 62.5 (8.3) years. MBFR was performed in a subgroup of 54 (84 %) of these women. Mean native T1 was 1023 (86) and ECV (%) was 33.7 (3.5); none had focal fibrosis. Median (IQR) CFVR was 2.3 (1.9; 2.7), 23 (36 %) had CFVR < 2 indicating coronary microvascular disease, and median MBFR was 2.7 (2.2; 3.0) and 19 (35 %) had a MBFR value below 2.5. No significant correlations were found between CFVR and ECV or native T1 (R (2) = 0.02; p = 0.27 and R (2) = 0.004; p = 0.61, respectively). There were also no correlations between MBFR and ECV or native T1 (R (2) = 0.1; p = 0.13 and R (2) = 0.004, p = 0.64, respectively). CFVR and MBFR were correlated to hypertension and heart rate. CONCLUSION: In women with angina and no obstructive coronary artery disease we found no association between measures of coronary microvascular disease and myocardial fibrosis, suggesting that myocardial ischemia induced by coronary microvascular disease does not elicit myocardial fibrosis in this population. The examined parameters seem to provide independent information about myocardial and coronary disease. BioMed Central 2016-11-04 /pmc/articles/PMC5096323/ /pubmed/27809867 http://dx.doi.org/10.1186/s12968-016-0295-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Mygind, Naja Dam Michelsen, Marie Mide Pena, Adam Qayyum, Abbas Ali Frestad, Daria Christensen, Thomas Emil Ghotbi, Adam Ali Dose, Nynne Faber, Rebekka Vejlstrup, Niels Hasbak, Philip Kjaer, Andreas Prescott, Eva Kastrup, Jens Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study |
title | Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study |
title_full | Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study |
title_fullStr | Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study |
title_full_unstemmed | Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study |
title_short | Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study |
title_sort | coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the ipower study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096323/ https://www.ncbi.nlm.nih.gov/pubmed/27809867 http://dx.doi.org/10.1186/s12968-016-0295-5 |
work_keys_str_mv | AT mygindnajadam coronarymicrovascularfunctionandmyocardialfibrosisinwomenwithanginapectorisandnoobstructivecoronaryarterydiseasetheipowerstudy AT michelsenmariemide coronarymicrovascularfunctionandmyocardialfibrosisinwomenwithanginapectorisandnoobstructivecoronaryarterydiseasetheipowerstudy AT penaadam coronarymicrovascularfunctionandmyocardialfibrosisinwomenwithanginapectorisandnoobstructivecoronaryarterydiseasetheipowerstudy AT qayyumabbasali coronarymicrovascularfunctionandmyocardialfibrosisinwomenwithanginapectorisandnoobstructivecoronaryarterydiseasetheipowerstudy AT frestaddaria coronarymicrovascularfunctionandmyocardialfibrosisinwomenwithanginapectorisandnoobstructivecoronaryarterydiseasetheipowerstudy AT christensenthomasemil coronarymicrovascularfunctionandmyocardialfibrosisinwomenwithanginapectorisandnoobstructivecoronaryarterydiseasetheipowerstudy AT ghotbiadamali coronarymicrovascularfunctionandmyocardialfibrosisinwomenwithanginapectorisandnoobstructivecoronaryarterydiseasetheipowerstudy AT dosenynne coronarymicrovascularfunctionandmyocardialfibrosisinwomenwithanginapectorisandnoobstructivecoronaryarterydiseasetheipowerstudy AT faberrebekka coronarymicrovascularfunctionandmyocardialfibrosisinwomenwithanginapectorisandnoobstructivecoronaryarterydiseasetheipowerstudy AT vejlstrupniels coronarymicrovascularfunctionandmyocardialfibrosisinwomenwithanginapectorisandnoobstructivecoronaryarterydiseasetheipowerstudy AT hasbakphilip coronarymicrovascularfunctionandmyocardialfibrosisinwomenwithanginapectorisandnoobstructivecoronaryarterydiseasetheipowerstudy AT kjaerandreas coronarymicrovascularfunctionandmyocardialfibrosisinwomenwithanginapectorisandnoobstructivecoronaryarterydiseasetheipowerstudy AT prescotteva coronarymicrovascularfunctionandmyocardialfibrosisinwomenwithanginapectorisandnoobstructivecoronaryarterydiseasetheipowerstudy AT kastrupjens coronarymicrovascularfunctionandmyocardialfibrosisinwomenwithanginapectorisandnoobstructivecoronaryarterydiseasetheipowerstudy AT coronarymicrovascularfunctionandmyocardialfibrosisinwomenwithanginapectorisandnoobstructivecoronaryarterydiseasetheipowerstudy |